Paper40933372
An impact of type 2 diabetes mellitus on NKT-like cell population in humans: a new insight into impaired immune response in hyperglycemia.
Adamska-Fita E and 5 others. Front Endocrinol (Lausanne), 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. An impact of type 2 diabetes mellitus on NKT-like cell population in humans: a new insight into impaired immune response in hyperglycemia. Papers, record 40933372. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40933372
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An impact of type 2 diabetes mellitus on NKT-like cell population in humans: a new insight into impaired immune response in hyperglycemia.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Natural Killer T-Cells | Major topic |
| Hyperglycemia | Major topic |
| Humans | |
| Male | |
| Middle Aged | |
| Female | |
| Aged | |
| Adult |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23479618 | B cells promote inflammation in obesity and type 2 diabetes through regulation of T-cell function and an inflammatory cytokine profile. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23479618 | PubMed |
| 2 | 28649243 | Distinct Blood and Visceral Adipose Tissue Regulatory T Cell and Innate Lymphocyte Profiles Characterize Obesity and Colorectal Cancer. | Front Immunol | 2017 | https://conductscience.org/library/papers/28649243 | PubMed |
| 3 | 39407333 | Metabolic reprogramming of macrophages in the context of type 2 diabetes. | Eur J Med Res | 2024 | https://conductscience.org/library/papers/39407333 | PubMed |
| 4 | 17454264 | Regulation of type 1 diabetes by NKT cells. | Int Rev Immunol | 2007 | https://conductscience.org/library/papers/17454264 | PubMed |
| 5 | 22252015 | Inflammation and type 2 diabetes. | Diabetes Metab | 2012 | https://conductscience.org/library/papers/22252015 | PubMed |
| 6 | 22547395 | High frequency of activated natural killer and natural killer T-cells in patients with new onset of type 2 diabetes mellitus. | Exp Biol Med (Maywood) | 2012 | https://conductscience.org/library/papers/22547395 | PubMed |
| 7 | 22493234 | Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22493234 | PubMed |
| 8 | 19259343 | Intracellular bacterial infection and invariant NKT cells. | Yonsei Med J | 2009 | https://conductscience.org/library/papers/19259343 | PubMed |
| 9 | 9127889 | The role of cytokines in the immune response to tuberculosis. | Res Immunol | 1996 | https://conductscience.org/library/papers/9127889 | PubMed |
| 10 | 34502425 | NKT and NKT-like Cells in Autoimmune Neuroinflammatory Diseases-Multiple Sclerosis, Myasthenia Gravis and Guillain-Barre Syndrome. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34502425 | PubMed |
| 11 | 27409423 | Altered phenotypic and functional characteristics of CD3+CD56+ NKT-like cells in human gastric cancer. | Oncotarget | 2016 | https://conductscience.org/library/papers/27409423 | PubMed |
| 12 | 21644914 | The role of natural killer T (NKT) cells in the pathogenesis of type 1 diabetes. | Curr Diabetes Rev | 2011 | https://conductscience.org/library/papers/21644914 | PubMed |
| 13 | 22981538 | Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production. | Immunity | 2012 | https://conductscience.org/library/papers/22981538 | PubMed |
| 14 | 37082729 | Dysfunction of circulating CD3+CD56+ NKT-like cells in type 2 diabetes mellitus. | Int J Med Sci | 2023 | https://conductscience.org/library/papers/37082729 | PubMed |
| 15 | 16275765 | Differential antitumor immunity mediated by NKT cell subsets in vivo. | J Exp Med | 2005 | https://conductscience.org/library/papers/16275765 | PubMed |
| 16 | 11877485 | Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining. | J Exp Med | 2002 | https://conductscience.org/library/papers/11877485 | PubMed |
| 17 | 30618112 | Relationship between natural killer cell activity and glucose control in patients with type 2 diabetes and prediabetes. | J Diabetes Investig | 2019 | https://conductscience.org/library/papers/30618112 | PubMed |
| 18 | 24554505 | Circulating CD3+56+ cell subset in pre-diabetes. | Exp Clin Endocrinol Diabetes | 2014 | https://conductscience.org/library/papers/24554505 | PubMed |
| 19 | 34777920 | PD-1 blockade improves the anti-tumor potency of exhausted CD3+CD56+ NKT-like cells in patients with primary hepatocellular carcinoma. | Oncoimmunology | 2021 | https://conductscience.org/library/papers/34777920 | PubMed |
| 20 | 16698943 | Comparative gene expression analysis of NKT cell subpopulations. | J Leukoc Biol | 2006 | https://conductscience.org/library/papers/16698943 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42719816 | Significance of innate immune surveillance in emphysematous pancreatitis. | Front Immunol | 2026 | https://conductscience.org/library/papers/42719816 | PubMed |
| 42038501 | Pathophysiological mechanisms and clinical management of type 2 diabetes mellitus complicated with anal fistula. | Front Surg | 2026 | https://conductscience.org/library/papers/42038501 | PubMed |
| 41156469 | Vitamin D May Increase the Number of CD4-CD8+ NKT-like Cells in Humans-A Novel Insight into Potential Immunomodulatory Action. | Nutrients | 2025 | https://conductscience.org/library/papers/41156469 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| NCAM1 | 4684 | PubTator's text mining | https://conductscience.org/library/genes/4684 | NCBI Gene |
| SRPRA | 6734 | PubTator's text mining | https://conductscience.org/library/genes/6734 | NCBI Gene |
| TRBV20OR9-2 | 6962 | PubTator's text mining | https://conductscience.org/library/genes/6962 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40933372
GET https://conductscience.org/api/papers/v1/40933372/references?page=2